WallStreetZenWallStreetZen

NASDAQ: SNTI
Senti Biosciences Inc Stock Ownership - Who owns Senti Biosciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Senti Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kanya RajangamPres. Chief Med. Dev. Off.2025-03-1033,000$2.25
$74.25kBuy
Timothy K. LuCEO2025-02-06545$4.36
$2.38kSell
Kanya RajangamPres. Chief Med. Dev. Off.2025-02-06182$4.37
$795.34Sell
Timothy K. LuCEO2025-02-043,922$4.07
$15.96kSell
Kanya RajangamPres. Chief Med. Dev. Off.2025-02-041,297$4.07
$5.28kSell

1 of 1

SNTI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SNTI insiders and whales buy or sell their stock.

SNTI Shareholders

What type of owners hold Senti Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celadon Partners Spv 2437.19%9,777,000$12.81MInsider
Omid Farokhzad34.72%9,128,403$11.96MInsider
Nea Management Company LLC14.36%3,775,615$4.95MInstitution
Bayer Healthcare LLC10.69%2,809,848$3.68MInsider
Philip J. Lee3.56%936,424$1.23MInsider
Nantahala Capital Management LLC3.38%888,000$1.16MInstitution
Timothy K. Lu3.16%830,118$1.09MInsider
Mostafa Ronaghi2.72%715,500$937.31kInsider
Vanguard Group Inc2.34%616,073$807.06kInstitution
Curt A. Herberts Iii1.73%454,208$595.01kInsider

1 of 3

SNTI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SNTI18.58%81.42%Net Buying
SKYE2.73%97.27%Net Selling
FGEN8.64%91.36%Net BuyingNet Buying
RNXT19.41%11.51%Net BuyingNet Buying
DARE3.80%96.20%
View Top Biotech Stocks

Senti Biosciences Stock Ownership FAQ

Who owns Senti Biosciences?

Senti Biosciences (NASDAQ: SNTI) is owned by 22.30% institutional shareholders, 97.70% Senti Biosciences insiders, and 0.00% retail investors. Celadon Partners Spv 24 is the largest individual Senti Biosciences shareholder, owning 9.78M shares representing 37.19% of the company. Celadon Partners Spv 24's Senti Biosciences shares are currently valued at $12.81M.

If you're new to stock investing, here's how to buy Senti Biosciences stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.